Medication Reconciliation Best Practices

Medication reconciliation is not merely an administrative task—it is a critical safeguard against patient harm and a cornerstone of high-quality clinical care. Every transition in a patient's journey, from hospital admission to discharge or during a specialist visit, presents a risk for medication errors. A robust reconciliation process systematically identifies and resolves these discrepancies, protecting patient safety and ensuring therapeutic continuity. Mastering this process is essential for pharmacists, nurses, and physicians who collaborate to create a single, accurate, and actionable medication list.

What is Medication Reconciliation?

Medication reconciliation is defined as the systematic and comprehensive process of creating the most accurate list possible of all medications a patient is taking—including drug name, dosage, frequency, and route—and comparing that list against the physician's admission, transfer, or discharge orders. The goal is to identify and resolve any discrepancies—unintended differences between what the patient was taking and what is now being ordered. These discrepancies can include omissions, duplications, dosing errors, or drug interactions.

The process is not a one-time event but a continuous cycle that must occur at every point of care transition: admission to a hospital, transfer between units, consultation with a new specialist, and discharge to home or another facility. Each transition is a vulnerability point where misinformation can be introduced, potentially leading to adverse drug events, readmissions, or therapeutic failure. A standardized approach is therefore non-negotiable for safe patient care.

Obtaining a Complete and Accurate Medication History

The foundation of effective reconciliation is a thorough medication history. Best practice dictates that this history is compiled from multiple, corroborating sources, as relying on any single source is prone to error. The process is often described as using a "brown bag" approach. You should start by interviewing the patient or their caregiver, but then verify and expand that information.

Key sources include:

• Patient/Caregiver Interview: Ask about prescription medications, over-the-counter drugs, herbal supplements, vitamins, and topical products. Use open-ended questions (e.g., "What do you take to help you sleep?" rather than "Do you take a sleep aid?").
• Prescription Fill Records: Contact the patient's community pharmacy or use a regional pharmacy network to obtain a verified fill history, which is often more reliable than patient recall.
• Primary Care or Specialist Records: Review recent clinic notes or contact the prescribing provider's office.
• Previous Discharge Summaries: These are vital for understanding what medications were intended for continued use after the last hospitalization.

For example, consider Mrs. Alvarez, an 78-year-old admitted for heart failure. She reports taking her "heart pill" (lisinopril 10mg daily) and a "water pill" (furosemide 40mg daily). A call to her pharmacy reveals she also fills atorvastatin and has recently been prescribed gabapentin for neuropathy, which she forgot to mention. This comprehensive history prevents the unintentional omission of two critical medications.

Resolving Discrepancies with Clinical Judgment

Once the pre-admission medication list is established, it must be compared against new admission or transfer orders. Every difference must be evaluated. Not all discrepancies are errors; some are intentional therapeutic changes by the prescriber. The core task is to determine which are intentional and which are unintentional omissions, additions, or dose changes.

The resolution process requires collaboration and clinical reasoning. For each discrepancy, you must:

1. Identify: Clearly note the difference (e.g., home medication: metoprolol tartrate 50mg twice daily; admission order: metoprolol succinate 100mg daily).
2. Investigate: Contact the prescriber to clarify intent. Is this a therapeutic substitution, a dose adjustment based on the acute illness, or an oversight?
3. Resolve: Document the final decision and the rationale. In the metoprolol example, the prescriber may have intentionally switched to a long-acting formulation for better adherence post-discharge. This intent must be clearly communicated.

The most dangerous discrepancies are often unintentional omissions of essential medications, such as anticoagulants, anticonvulsants, or anti-Parkinson's drugs, which can lead to immediate clinical deterioration.

Documentation and Communication of the Reconciled List

Accurate documentation finalizes the reconciliation process and creates a legal record. The reconciled medication list, including doses, frequencies, and routes, must be entered into the patient's permanent health record in a standardized location. Crucially, the rationale for any intentional change (e.g., "Holding apixaban due to active GI bleed; will reassess in 48 hours") must be documented alongside it. This provides clarity for all subsequent care team members and prevents the "change" from being misinterpreted as an error later.

Communication is the parallel requirement. The updated, reconciled list must be actively shared with the patient and their family, as well as with all relevant members of the care team. The patient must understand what medications they are to take while in the current care setting, why any changes were made, and what to expect. This transparent communication engages the patient as a partner in their own safety.

Discharge Reconciliation and Patient Education

The discharge transition carries the highest risk for post-discharge adverse events. Discharge medication reconciliation involves creating a final, accurate list of medications to be taken at home. This list must reconcile the pre-admission medications, any changes made during the stay, and new prescriptions.

Best practices for discharge include:

• Verifying Accuracy: Compare the discharge instructions against the final reconciled inpatient list and the original history.
• Providing a Patient-Friendly List: Furnish a clear, legible list written in plain language, indicating which medications to continue, which to stop, and which are new.
• Conducting a "Teach-Back" Session: Have the patient explain back to you their new medication regimen in their own words. This is the most effective way to confirm understanding.
• Transmitting to Next Provider: The finalized discharge medication list must be communicated to the patient's primary care provider and next pharmacist within 24-48 hours of discharge to ensure continuity.

Common Pitfalls

1. Relying Solely on the Patient's Memory or a Current List: Even a typed list from home may be outdated. Always seek verification from at least one other source, preferably a pharmacy fill history.
2. Failing to Document the "Why": Documenting that lisinopril was held is insufficient. Failing to document "held due to acute kidney injury with creatinine of 2.5 mg/dL" leaves the next clinician to guess at the rationale, potentially leading to an unsafe restart.
3. Inadequate Patient Communication at Discharge: Simply handing a patient a printed list is ineffective. Without a verbal "teach-back" conversation, patients are likely to misunderstand which medications to continue or how to take new ones, leading to non-adherence or duplication.
4. Treating Reconciliation as a One-Time Task: The process is dynamic. A medication list reconciled on admission is obsolete if not updated when new medications are started or stopped during the hospital stay. Reconciliation must be revisited with any significant change in condition or therapy.

Summary

• Medication reconciliation is a mandatory, systematic process at every care transition to prevent errors and ensure patient safety.
• A complete medication history requires gathering information from multiple sources, including the patient, community pharmacy, and other providers, to build an accurate pre-admission list.
• Each discrepancy between the history and new orders must be intentionally reviewed, resolved with the prescriber, and documented with a clear clinical rationale.
• Communication of the reconciled list is twofold: to the entire care team for continuity and to the patient/caregiver for understanding and engagement.
• The discharge process is a high-risk phase that demands meticulous verification, patient education using the "teach-back" method, and prompt transmission of information to the next care provider.